Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02363270 · ClinicalTrials.gov registry record · NA

Ketamine: Comparison of IV Push vs. IV Drip

A NA study of Pain, sponsored by Antonios Likourezos.

Completed
Registry status
NA
Development phase
48
Enrollment target
1
Study location

NCT02363270 is a NA study of Pain that has completed, run by Antonios Likourezos. The registered enrollment target is 48 participants, below the 304-participant average among 374 other Pain trials with a reported enrollment target (84% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02363270, a NA study of Pain, has completed, sponsored by Antonios Likourezos.

COMPLETED
Registry status
NA
Development phase
48 participants
Enrollment target
1
Study location

Study Summary

Our previous published research comparing the efficacy of intravenous ketamine to morphine has shown ketamine to provide equivalent relief of moderate to severe acute pain in emergency medicine patients. Secondary analysis of the previous published research has also revealed ketamine to have statistically more side effects. The investigators believe that increasing the time of administration of the ketamine, from a push injection to a drip infusion, will minimize the side effects experienced by recipients of ketamine.

Conditions Studied

Interventions

  • PROCEDURE Ketamine

Study Locations (1)

New York

  • Maimonides Medical Center - Brooklyn

Trial Details

FieldValue
Enrollment Target 48 participants
Start Date 2015-04-01
Est. Completion 2017-02-28
Phase NA

Sponsor

Antonios Likourezos

33 total trials

What the Registry Record Tells You About NCT02363270

The ClinicalTrials.gov registry entry for NCT02363270 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 48 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 304-participant average among 374 other Pain trials with a reported enrollment target (84% lower). The listed sponsor is Antonios Likourezos, which has 33 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Pain appearing as the primary indexed condition, and to 1 intervention - of which Ketamine is the first listed.

NCT02363270 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT02363270 about?

NCT02363270 is a clinical study titled "Ketamine: Comparison of IV Push vs. IV Drip". Our previous published research comparing the efficacy of intravenous ketamine to morphine has shown ketamine to provide equivalent relief of moderate to severe acute pain in emergency medicine patients. Secondary analysis of the previous published research has also revealed ketamine to have statist...

What is the current status of trial NCT02363270?

This trial is currently completed. It is a NA study. The enrollment target is 48 participants. The study started on 2015-04-01. Estimated completion is 2017-02-28.

What conditions does trial NCT02363270 study?

This clinical trial studies the following conditions: Pain.

What interventions are being tested in trial NCT02363270?

The interventions under investigation include: Ketamine (PROCEDURE).

Who is sponsoring clinical trial NCT02363270?

This trial is sponsored by Antonios Likourezos, which has 33 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02363270 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.